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Summary
Human AKTIP and mouse Ft1 are orthologous ubiquitin E2 variant proteins involved
in telomere maintenance and DNA replication. AKTIP also interacts with A- and B-
type lamins. These features suggest that Ft1 may be implicated in aging regulatory
pathways. Here, we show that cells derived from hypomorph Ft1 mutant (Ft1kof/kof)
mice exhibit telomeric defects and that Ft1kof/kof animals develop progeroid traits,
including impaired growth, skeletal and skin defects, abnormal heart tissue, and
sterility. We also demonstrate a genetic interaction between Ft1 and p53. The anal-
ysis of mice carrying mutations in both Ft1 and p53 (Ft1kof/kof; p53ko/ko and Ft1kof/
kof; p53+/ko) showed that reduction in p53 rescues the progeroid traits of Ft1
mutants, suggesting that they are at least in part caused by a p53-dependent DNA
damage response. Conversely, Ft1 reduction alters lymphomagenesis in p53 mutant
mice. These results identify Ft1 as a new player in the aging process and open the
way to the analysis of its interactions with other progeria genes using the mouse
model.
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1 | INTRODUCTION
Human AKTIP, mouse Ft1, and Drosophila Pendolino (Peo) are
orthologous ubiquitin E2 variant proteins involved in telomere main-
tenance (Burla et al., 2015; Cenci, Ciapponi et al., 2015). AKTIP
mediates proper telomere replication, binds telomeric DNA and the
shelterins TRF1 and TRF2, and interacts with the DNA replication
machinery components PCNA and RPA70. We have previously sug-
gested that AKTIP works in concert with TRF1 to facilitate telomeric
DNA replication (Burla et al., 2015).
AKTIP also interacts with A- and B-type lamins and is enriched
at the nuclear rim (Burla, Carcuro, et al., 2016). Reduction in AKTIP
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in human fibroblasts results in senescent phenotypes, including the
activation of the p53 pathway, nuclear deformity, heterochromatin
alterations, and senescence. In addition, AKTIP reduction affects
lamin A expression in human cells (Burla, Carcuro, et al., 2016). Alto-
gether, the properties of AKTIP place this protein at the crossroad
of multiple pathways that have been associated with progeroid phe-
notypes.
The Hutchinson–Gilford progeria syndrome (HGPS) is the best-
characterized example of progeria, caused by a mutation in exon 11
of the LMNA gene leading to the production of a truncated form of
lamin A (De Sandre-Giovannoli et al., 2003). Patients with HGPS
develop multiorgan abnormalities, including skeletal defects and
absence of subcutaneous fat. They show a limited growth and die in
the teenage years, prevalently due to cardiovascular problems lead-
ing to infarction or stroke (Hennekam, 2006). Mouse models reflect
several aspects of the human disease; the LAKI model, for example,
carrying the G608G mutation in the LMNA gene, is characterized by
reduced lifespan and body weight, and skeletal and skin defects
(Osorio, Navarro, et al., 2011).
The idea that lamins play a pivotal role in determining premature
aging is also supported by the discovery of progeroid disorders dif-
ferent from HGPS. For example, restrictive dermopathy patients
carry recessive mutations in the ZMPSTE24 gene, which encodes the
proteolytic enzyme involved in lamin A maturation (Barrowman,
Wiley, Hudon-Miller, Hrycyna & Michaelis, 2012). Also, in this case,
a mouse model replicates the progeroid phenotype of the disease
(Osorio, Ugalde, et al., 2011). A partial recovery of the ZMPSTE24/
phenotype is obtained by depletion of the tumor suppressor protein
p53, pointing to a role of DNA damage in the pathophysiology of
this progeria (Varela et al., 2005).
In addition to the LMNA gene, several genes involved in DNA
metabolism have been implicated in progeroid syndromes.
They include the WRN and BLM genes, which encode members
of the RecQ DNA helicase family and are responsible for the
Werner and Bloom syndromes, respectively (Bachrati & Hickson,
2003).
Telomere dysfunctions have also been linked to progerias.
Dyskeratosis congenita, which is caused by mutations in
telomere-related genes, has progeroid phenotypic traits (Dokal,
2011).
The involvement of AKTIP in telomere maintenance and
regulation of lamin A (Burla et al., 2015; Burla, Carcuro, et al.,
2016) prompted us to investigate whether this protein contributes
to preventing premature aging. We thus generated mice bearing a
mutation in the Ft1 gene. We report here that Ft1 mutant mice
exhibit multiple progeroid traits, including impaired growth, skeletal
and skin defects, and sterility. We also demonstrate an inter-
play between Ft1 and p53. Ft1 mutant mice carrying mutations in
p53 (Ft1kof/kof;p53ko/ko and Ft1kof/kof;p53+/ko) showed a partial
rescue of the progeroid traits observed in Ft1 single mutants,
suggesting that these traits are at least in part caused by the
p53-mediated response to the DNA damage elicited by mutation
in Ft1.
2 | RESULTS
2.1 | Generation of Ft1 kof mice and
characterization of derived MEFs
Given that AKTIP is required for DNA replication and cell prolifera-
tion (Burla et al., 2015), we reasoned that full knockout (ko) of Ft1
would cause physiological damage incompatible with mouse sur-
vival. Thus, we produced animals with reduced Ft1 levels using the
knockout first (kof) strategy, based on the insertion into the target
gene (referred as kof allele) of the bgeok cassette (Testa et al.,
2004) (Figure 1a), which traps and truncates Ft1 nascent transcript
reducing the expression of the gene (Figure 1a). Transgenic foun-
ders and subsequent generations were screened by PCR (Fig-
ure 1b), and two independent kof lines (lines 107 and 588) were
selected and analyzed for mRNA reduction. q-PCR on tail biopsies
from Ft1kof/kof and Ft1+/kof animals showed that Ft1 expression was
significantly reduced compared to wild-type (wt) mice (Figure 1c).
In Ft1kof/kof mice from lines 107 and 588, Ft1 expression was
reduced to 18% and 12%, respectively; in Ft1+/kof animals from the
same lines, Ft1 expression was reduced to 64% and 52% (Fig-
ure 1c). The analysis of 573 F1 progeny from crosses between
Ft1+/kof conformed to Mendelian ratios, although we observed a
slight nonsignificant trend of embryonic lethality of Ft1kof/kof ani-
mals (Figure 1d).
We next investigated whether MEFs from Ft1kof/kof mice exhibit
the same phenotypes as those previously observed in RNAi cells
depleted of AKTIP or Ft1 (Burla et al., 2015; Burla, Carcuro, et al.,
2016). We first checked the Ft1 subcellular localization by immunos-
taining MEFs with an anti-Ft1 antibody. In human cells, AKTIP is
enriched at the nuclear rim where it partially co-localizes with lamins
(Burla, Carcuro, et al., 2016). Consistent with these results, Ft1+/+
MEFs displayed a Ft1 signal at the nuclear periphery (Figure 1e),
while the signal was undetectable in the Ft1kof/kof MEFs (Figure 1e,f).
In line with these results, Western blotting showed a strong reduc-
tion of Ft1 in Ft1kof/kof MEF extracts (Figure 1g).
We then asked whether MEFs from Ft1kof/kof mice activate the
DNA damage response (DDR) and exhibit telomere defects. Com-
pared to wt MEFs, Ft1kof/kof MEFs displayed substantial increases in
53BP1 and cH2AX foci, indicating that Ft1 is required for the main-
tenance of genome integrity (Figure 2a–f). In addition, double
immunofluorescence staining of cH2AX and TRF1 showed that
Ft1kof/kof MEFs exhibit a significant increase in cH2AX/TRF1 co-
labeled foci (Telomere Dysfunction induced Foci, TIFs) compared to
control MEFs, suggesting that the DDR of mutant cells was at least
in part linked to telomere dysfunction (Figure S1c,d). To determine
the nature of telomere defects in Ft1kof/kof MEFs, we performed
in situ hybridization with a TTAGGG probe. The analysis of meta-
phase spreads showed that Ft1kof/kof MEFs exhibit multiple telomeric
signals (MTS, also known as fragile telomeres) and sister telomere
associations (STA) (Figure 2g–i and Figure S1e). These types of
telomere aberrations are considered hallmarks of defective telomere
replication (Sfeir et al., 2009). Ft1kof/kof MEFs showed a small but not
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statistically significant increase in telomere fusions compared to
matched control MEFs. In addition, Ft1kof/kof MEFs displayed a fre-
quency of telomeres with a TTAGGG signal comparable to that of
control, confirming (Burla et al., 2015) that an impairment of the Ft1
function does not result in telomere loss (Figure S1a,b).
Finally, we evaluated the status of lamin A in MEFs. Consistent
with our previous results on human AKTIP (Burla, Carcuro, et al.,
2016), wt cells displayed partial co-localization of lamin A with Ft1
(Figure S1f). Ft1kof/kof MEFs cells showed an altered lamin A distribu-
tion with a reduced concentration of lamin A at the nuclear rim (Fig-
ure 2j–l).
Altogether, our results indicate that Ft1kof mutation cause DDR,
telomere defects and abnormal lamin distribution, which are well-
known hallmarks of aging. We thus asked whether Ft1kof mutant
mice exhibit signs of premature aging. In mouse models of progeroid
disorders, premature aging alterations mostly affect body growth,
fertility, bones, skin and heart. We therefore focused on these phe-
notypic traits in our analyses on Ft1kof mutant mice.
2.2 | Ft1 kof mice display growth defects, reduced
lifespan and sterility
Macroscopic observation of Ft1kof/kof mice revealed that mutant ani-
mals (n = 170) display a significant reduction in body weight com-
pared to controls (Figure 3a–c); 21% of the animals showed a 30%
reduction in body weight compared to controls; henceforth, we will
F IGURE 1 Generation of Ft1kof/kof mice. (a) wt allele (+) of Ft1 and kof cassette inserted into the gene to generate animals with reduced
Ft1 expression. F, forward; R, reverse; Frt, target site for FLP recombinase; loxP, target site for Cre recombinase; SA, splicing acceptor site
element from engrailed 2; IRES, internal ribosomal entry site from the Encephalomyocarditis virus; lacZ, b-galactosidase gene; neo, neomycin
phosphotransferase, selectable marker. (b) PCR of gDNA from Ft1+/+, Ft1+/kof, and Ft1kof/kof animals. (c) q-PCR on tail cDNA of animals from
two independent mouse lines. Results present the ratios between Ft1 exons 6 and 3 normalized to GAPDH. Ft1kof/kof mice n = 53, Ft1+/kof
animals n = 15, and wt n = 30. ***p < .001 in Student’s t test. (d) Mendelian distribution; no significant difference between observed and
expected Ft1 kof/kof genotypes (p = .056 v2 test). (e) MEFs stained with anti-Ft1 antibody (red in merges). Scale bar 5 lm. (f) Frequency of MEF
nuclei showing Ft1 localization at the nuclear rim. Graphs show mean  SEM; n = 50 cells; ***p < .001 in Student’s t test. (g) Western
blotting on MEF extracts
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refer to these mice as severely affected Ft1kof/kof mice, abbreviated
with SA Ft1kof/kof or SA mutant mice. By selecting a cohort of ani-
mals with a mild (non-SA) phenotype, we monitored body weight
over a 100-week period and subdivided lifespan in three major inter-
vals: young 3 < weeks < 20; juvenile 21 < weeks < 60; adult
61 < weeks < 100. We observed that the difference in body weight
between wt and Ft1kof/kof animals significantly increases as mice age
(Figure 3b,c). Ft1kof/kof mice had a reduced lifespan compared to wt,
SA Ft1kof/kof animals died at day 12–14, while the remaining popula-
tion displayed a median survival of 113 weeks (Figure 3d). We also
observed reduced fertility in inbreeding; when Ft1kof/kof non-SA
males were crossed with Ft1+/kof females, we did not observe any
pregnancies (Figure 3e). Altogether, these observations show that
Ft1 expression is critical for mouse growth, survival and fertility.
2.3 | Ft1 kof mice display skeletal alterations
Bone is altered in progeroid patients and mouse models for progeria
syndromes (Bergo et al., 2002; Mounkes, Kozlov, Hernandez, Sullivan
& Stewart, 2003; Osorio, Navarro, et al., 2011). Radiographic analyses
of whole skeletons were collected at day 12 from eight SA Ft1kof/kof
mice and three wt animals. X-ray images showed reduced skeleton
size, craniofacial dysmorphism (Figure 4a), and kyphotic spine curva-
ture (Figure 4a,b). Long bones in SA mutant mice were 70% of wt,
consistent with the overall body size reduction in Ft1kof/kof mice (Fig-
ure 4c). This difference is evident in the magnification of femur and
tibia (Figure 4c). A reduction in size was also observed in tail vertebrae
(Figure 4d). Radiographic analysis further showed that femurs and tib-
iae from Ft1kof/kof mice are less reflective than wt bones. Quantifica-
tion of pseudocolored images from X-ray images revealed a
statistically significant difference between Ft1kof/kof and wt mice, sug-
gesting osteopenic defects in mutant animals (Figure 4e,f).
To further define bone tissue organization, we histologically ana-
lyzed sections from caudal vertebrae obtained from SA Ft1kof/kof
mice. Hematoxilyn and eosin (H&E) staining showed differences in
the growth plate of Ft1kof/kof animals compared to wt (Figure 4g),
while the marrow cavity appeared regularly formed in mutant mice.
The analysis of femur sections showed that Ft1kof/kof mice exhibit
F IGURE 3 Growth, lifespan, and fertility of Ft1kof/kof mice. (a) Pictures of age-matched mice showing body size differences between Ft1kof/
kof animals and wt. (b) Body weight analysis during growth of Ft1kof/kof and wt. Student’s t test ***p < .001. (c) D(C)t in lifespan intervals
showing that difference in body weight increases with mouse age; ***p < .001 in Student’s t test. (d) Kaplan–Meier survival curve of Ft1kof/kof
and wt mice; ***p < .001—log-rank—Mantel–Cox test. (e) Pups generated by mice of different genotypes. Whiskers represent the minimum
and the maximum values and the boxes the 25th to the 75th percentile; median values are shown as a line within the boxes. *p < .05;
***p < .001 in Student’s t test. See also Table S2
F IGURE 2 DNA damage, telomere aberrations and lamin A alterations in Ft1kof/kof MEFs. (a–c) Staining for anti-53BP1 (red in merges) in
MEFs (a) and quantification (b, c). (d–f) Staining with anti-cH2AX (red in merges) in MEFs (d) and quantification (e, f). Graphs (b, c, e, f) show
mean  SEM; **p < .01; ***p < .001 in Student’s t test. Scale bars 5 lm. (g) Partial DAPI-stained (red) metaphases from MEFs showing
telomeric FISH signals (black and white; green in merges) including enlargement of single chromosomes with multiple telomeric signals (MTS).
MTS are indicated by arrows. (h, i) MTS (h) and STA (i) frequencies in MEFs. Graphs show mean  SEM; *p < .05; ***p < .001 in v2 test. (j)
Immunostaining for lamin A in MEF nuclei. Scale bar 5 lm. (k) Quantification of lamin A signal at nuclear rim in MEFs. Graphs show
mean  SEM; *p < .05 in Student’s t test from two independent experiments on two MEF cultures (n = 100 cells/culture). (l) Z stack
projections and quantification showing the altered distribution of lamin A in Ft1kof/kof MEF nuclei. See also Figure S1
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regular columnar and conjugational cartilage, although slightly
shorter than controls (Figure 4g). In mutant mice, newly formed
bone trabeculae were also shorter, with a poorly defined osteoblastic
rim, as compared to wt (Figure 4h). TRAP cytochemistry did not
reveal significant differences in osteoclast numbers relative to bone
surfaces between Ft1kof/kof samples and controls, suggesting that the
F IGURE 4 Bone alterations in Ft1kof/kof mice. (a) X-ray on total body of Ft1kof/kof and wt mice at day 12. Arrowheads indicate spine defects
and craniofacial dysmorphisms in Ft1kof/kof animals. (b) Quantification of the angle formed by the cervical and thoracic vertebrae; ***p < .001
in Student’s t test. (c) X-ray images of femurs and tibias from Ft1kof/kof and wt at day 12. (d) X-ray of tail and magnification of caudal vertebrae
(dotted white box) of Ft1kof/kof and wt at day 12. (e, f) Pseudocolored femur images (e) and relative quantification (f) showing that X-ray
absorption is lower in Ft1kof/kof as compared to wt. Student’s t test, *p < .05. (g) H&E-stained sections of caudal vertebrae (top) and femurs
(bottom) of Ft1kof/kof and wt at day 12. (h, i) TRAP (h) and relative quantification (i) on femur sections shows no significant differences in
TRAP-positive cells between Ft1kof/kof and matched wt (p = .67 Student’s t test). See also Table S2
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osteopenic defects cannot be ascribed to increased osteoclastogene-
sis (Figure 4i).
Altogether, these results show that mutations in Ft1 cause bone
defects that partially phenocopy those observed in progeroid models
caused by mutations in lamin coding genes or in genes involved in DNA
metabolism (Bergo et al., 2002; Chen et al., 2012; Saeed et al., 2011).
2.4 | Ft1 kof animals display skin and heart
alterations
Several studies have shown that skin and heart are typically altered
in premature aging disorders associated with impaired DNA
metabolism, lamin, or telomere defects (Bergo et al., 2002; Cao &
Hegele, 2003; Mounkes et al., 2003; Watson et al., 2013). We found
that in SA Ft1kof/kof mice adipose tissue deposits are strongly
reduced compared to age-matched controls (Figure 5a). The analysis
on H&E-stained skin sections clearly showed the absence of subcu-
taneous fat layer in SA mutant animals, a defect similar to the skin
defects described in mice carrying mutations in the lamin A coding
gene (Mounkes et al., 2003) (Figure 5b).
The heart of SA Ft1kof/kof mice was smaller than in controls, with
a reduction in size proportional to the overall body reduction (Fig-
ure 5c). In addition, analysis of H&E-stained hearts of Ft1kof/kof ani-
mals and wt mice showed a difference in tissue architecture. In
F IGURE 5 Lipodystrophy and heart defects in Ft1kof/kof mice. (a) Pictures of skinned Ft1kof/kof and wt at day 12, showing loss of body fat
(yellow dot circles) in Ft1kof/kof animals. (b) H&E-stained skin sections of Ft1kof/kof and wt at day 12 showing reduction in fat layer. (c) H&E-
stained hearts from wt and Ft1kof/kof mice (top) at day 12, and magnification of the heart tissue (bottom). (d) Quantification showing that Ft1kof/
kof hearts have a higher number of nuclei per area compared to wt; **p < .01 in Student’s t test. (e) Images of cH2AX immunostaining of heart
sections from wt and Ft1kof/kof mice at day 12. (f) Percentages of cells showing more than five cH2AX foci in the heart sections shown in e.
Error bars indicate SEM; ***p < .001 in Student’s t test. (g) q-PCR quantification of the p21 senescence marker expression in wt and matched
Ft1kof/kof mice at day 12 and at 6 months after birth. *p < .05 and ***p < .001 in Student’s t test. See also Table S2
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hearts of SA Ft1kof/kof animals, there was no apparent fibrotic tissue
and the number of nuclei per area was higher than in wt hearts, sug-
gesting an increase in the nuclear/cytoplasmic ratio (Figure 5c,d).
To gain additional insight into the origin of the defects detected
in SA Ft1kof/kof hearts, we immunostained heart sections for cH2AX
to reveal DNA damage foci. In mutant hearts, the frequency of cells
with more than 5 foci was significantly higher than in controls, indi-
cating DDR activation (Figure 5e,f). We also investigated whether
mutant hearts express the p21 DDR and senescence marker to a
higher extent than to control hearts. q-PCR analysis revealed that
p21 is upregulated in heart extracts from both 12 days SA mutants
and 6-month non-SA Ft1kof/kof mice compared to age-matched con-
trols (Figure 5g).
Collectively, these results indicate that mutations in Ft1 affect
the skin and heart structural organization, and activate DDR and
senescence pathways.
2.5 | p53 and Ft1 genetically interact
p21 is a potent inhibitor of cyclin-dependent kinase (CDK) that
mediates p53-dependent cell cycle arrest in response to DNA dam-
age; it has been shown that p21 is activated by p53. We thus asked
whether p53 contributes to the phenotypic traits observed in
Ft1kof/kof mice. To test this possibility, we generated Ft1;p53 double
mutant using p53 ko mice (Jacks et al., 1994). Double-mutant mice
were examined for several phenotypic traits, particularly those
affected in Ft1kof/kof single mutants.
We first analyzed fertility of mutant animals. In contrast with
Ft1kof/kof male mice that were sterile, Ft1kof/kof; p53+/ko and Ft1kof/kof;
p53ko/ko male mice gave progeny when crossed to wt females, indi-
cating that mutation in one or both p53 alleles rescues sterility (Fig-
ure 6a). We next examined body weight and survival; the body
weight deficiency observed in Ft1kof/kof mice was rescued in
Ft1kof/kof;p53+/ko mutants at least until the 24th postnatal week.
However, after the 31st week, the body weight of Ft1kof/kof;p53+/ko
mutants was reduced compared to controls, although to a lesser
extent than in Ft1kof/kof;p53+/+ (Figure 6b). Interestingly, Ft1kof/kof;
p53+/ko animals did not exhibit an improvement in their viability as
compared to Ft1kof/kof;p53+/+; rather, the double mutation resulted in
additive lifespan reduction (Figure 6c).
Analysis of death causes revealed a further interplay between
Ft1 and p53 (Figure 6d,e and Figure S3). Homozygosity for Ft1kof did
not result in malignant tumors, and Ft1kof mutations were modestly
cancer-protective in a p53 ko background (Table S1 and Figure S3).
However, the simultaneous presence of mutations in Ft1 and of p53
loss induced multiorgan lymphomas (Figure 6d, Figure S3b–e), which
were not observed in p53 mutant animals that exhibit lymphomas in
single organs (Figure 6d, Figure S3f,g and Table S1). In addition Mice
with reduced levels of Ft1, both in the presence or absence of p53,
appeared to be sensitive to other pathologies, including hepatitis,
bone marrow aplasia, peritonitis, nephritis, and pneumonia (Fig-
ure 6e, and Table S1 and Figure S3h,i). Thus p53 deficiency in
Ft1kof/kof mutant mice rescues the sterility and the reduced body
weight phenotypes, but a concomitant deficiency of p53 and Ft1
affects lymphomagenesis.
2.6 | Ft1 mutant cells are sensitive to DNA
damaging agents
The DDR foci observed in the MEFs and heart of Ft1kof/kof mice, and
the telomeric aberrations found in Ft1kof/kof MEFs suggest that Ft1
mutant cells might be defective in DNA repair. To address this issue,
we determined the sensitivity of Ft1kof/kof MEFs to DNA damaging
agents. We exposed Ft1kof/kof MEFs to nonlethal doses of the radio-
mimetic compound bleomycin, which creates DNA double-strand
breaks (DSBs). Cell density assessment at 10 days after treatment
showed that Ft1kof/kof MEFs are significantly more sensitive to the
drug compared to passage-matched wt MEFs (Figure S4a). Increased
sensitivity of Ft1kof/kof MEFs to DNA damage was also observed
after treatment with hydroxyurea, which depletes the cells of dNTPs,
generating stalled replication forks that can collapse into DSBs (Fig-
ure S4b). Notably, the reduction in cell density observed in Ft1kof/kof
MEFs after bleomycin or hydroxyurea treatment was rescued by the
presence of a single p53ko mutant allele in the Ft1kof/kof background
(Figure 6f,g). In line with these results, the Western blotting analysis
showed that nonmutagenized Ft1kof/kof MEFs accumulate both p21
and p53 and that this accumulation was significantly reduced in
Ft1kof/kof;p53+/ko MEFs (Figure 6h and Figure S5a,b). Consistent with
the finding that p53 and p21 accumulation is associated with cell
senescence and reduced proliferation (Ibrahim et al., 2013; Sharpless
& Sherr, 2015), we observed a decrease in proliferation of Ft1kof/kof
MEFs compared to wt MEFs. We also observed an excessive dou-
blings of Ft1kof/kof;p53+/ko MEFs with respect to Ft1+/+;p53+/ko cells
(Figure 6i). An increase in the proliferation rate of MEFs bearing
mutation in p53 has been reported previously (Lang et al., 2004; Ma,
Choudhury, Hua, Dai & Li, 2013).
Collectively, these results suggest that Ft1 deficiency renders
cells more sensitive to DNA damaging agents, resulting in prolifera-
tion defects that are (over) rescued by the presence of a single
p53ko mutant allele.
3 | DISCUSSION
Human progeroid syndromes and their related animal models have
been instrumental to identify factors involved in normal human
aging. The cellular defects found in progeroid diseases that also char-
acterize normal human aging include DNA damage and genome
instability, telomere attrition, epigenetic alterations of histones, aber-
rations in the nuclear lamina, and cell senescence (de Boer et al.,
2002; Liu et al., 2005; Osorio, Ugalde, et al., 2011; Varela et al.,
2005).
Here we analyzed the cellular, developmental, and physiological
phenotypes of Ft1 mutant mice, focusing on traits related to the
aging process. Importantly, our analysis of MEFs from Ft1kof/kof mice
confirmed and extended our previous results obtained on the mouse
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and human cells depleted of Ft1 or AKTIP (Burla et al., 2015; Burla,
Carcuro, et al., 2016). Specifically, we showed that Ft1kof/kof mutant
MEFs exhibit fragile telomeres and sister telomere associations, TIFs,
DNA repair foci, increased sensitivity to bleomycin and hydroxyurea,
and reduced cell proliferation. In addition, we confirmed that in Ft1
mutant MEFs there is an alteration in lamin A, resulting in a strong
F IGURE 6 Ft1kof/kof mouse phenotype is p53 sensitive. (a) Pups generated by animals bearing mutations in Ft1 and/or p53; ***p < .001 in
Student’s t test. Whiskers represent the minimum and the maximum values observed for each mating and the boxes the 25th to the 75th
percentile. (b) Body weight in Ft1kof/kof animals in the presence or absence of a null mutation in p53; note that loss of a single p53 allele
dominantly rescues the Ft1-dependent body weight reduction; *p < .05; ***p < .001 in Student’s t test. (c) Survival of Ft1kof/kof;p53+/ko mice is
decreased compared to that of Ft1+/kof;p53+/ko and Ft1+/+;p53+/ko animals (p < .001—log-rank—Mantel–Cox test). (d, e) Case analysis on wt
mice and mice bearing mutations in p53 (p53ko/ko) and Ft1, showing that Ft1 mutation impacts on lymphomagenesis and inflammatory
conditions. See also Figure S3 and Table S1. (f, g) Cell survival response in MEFs from Ft1+/+;p53+/+, Ft1kof/kof;p53+/+, and Ft1kof/kof;p53+/ko mice
upon increasing doses of bleomycin (f) or hydroxyurea (HU) (g) showing that cells homozygous for mutations in Ft1 and bearing a null mutation
in p53 (p53+/ko) are less sensitive to DNA damage than Ft1 mutant cells bearing two wt copies of p53. Graphs show mean  SEM; **p < .01
in Student’s t test. (h) Western blotting analysis of p21 and p53 expression in Ft1+/+; p53+/+, Ft1kof/kof; p53+/+, and Ft1kof/kof;p53+/. (i)
Population doubling (pd), showing that Ft1kof/kof MEFs have a reduced pd compared to Ft1+/+ cells; this phenotype is rescued by a p53ko
mutation. Each dot represents the mean  SEM of the cumulative pd at the indicated day; *p < .05, ***p < .001 in Student’s t test. See also
Figures S4 and S5
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reduction in the lamin nuclear rim. Thus, Ft1 mutant MEFs display
many traits that have been previously observed in progeroid syn-
dromes and progeroid animal models, as well as in normal human
aging.
Consistent with the results on mutant MEFs, our analysis of
Ft1kof/kof mutant animals detected progeroid phenotypes. Ft1kof/kof
mice displayed multiple traits that have been previously observed in
several progeroid models (Table S2). We found that Ft1 mutant mice
have reduced body weight, fertility defects, and reduced lifespan, as
previously observed in models of laminopathies (Bergo et al., 2002;
Osorio, Navarro, et al., 2011) and telomeropathies (Martınez et al.,
2009). In addition, the growth defects of Ft1kof/kof mice were exacer-
bated with aging, suggesting that the effects of Ft1 mutations inter-
cept the normal aging-induced degeneration pathways. Ft1kof/kof mice
also displayed skin and bone defects, which were previously observed
in lamin mutant mice (Bergo et al., 2002; Mounkes et al., 2003; Oso-
rio, Navarro, et al., 2011), in Tert ko animals (Rudolph et al., 1999),
and in mice with reduced Trf1 expression (Martınez et al., 2009).
Skeletal alterations and lipodystrophy have been imputed to failures
in the proliferation of mesenchymal stem cell progenitors, which are
sensitive to lamin mutations and senescence (Scaffidi & Misteli,
2008). Mutant hearts were smaller than those of wt animals and
showed a higher nuclear density compared to wt, with an increase in
the nuclear/cytoplasmic ratio. In addition, we found that mutant
hearts display DNA damage and activation of the DDR, and up-regu-
lation of p21 expression. The relationships between increased DNA
damage and a change in nuclear density in the mutant hearts are
unclear. A possible explanation is that DNA damage and the related
inflammation process induce local cell reprogramming. This explana-
tion is consistent with the observation that cellular reprogramming
in vivo occurs following tissue injury (Yanger et al., 2013).
The fact that the organismal phenotypes observed in Ft1 mutant
animals have also been found in models specifically defective in
lamin structure and/or expression, or bearing mutations in genes
required for telomere maintenance or DNA repair, poses an interest-
ing question. Which of the cellular phenotypes observed in Ft1
mutant MEFs (defective lamin behavior, telomere dysfunction, DNA
damage) is responsible for the organismal progeroid phenotypes?
Answering this question is difficult because the traits that character-
ize Ft1 mutants at the cellular level are deeply interconnected. For
example, alterations in lamin function affect DNA replication and
repair, epigenetic modification of chromatin and transcription (Gon-
zalo & Kreienkamp, 2015). Moreover, multiple interactions link
telomeres to the lamin network, including the association of telom-
eres with the nuclear envelope (Burla, La Torre & Saggio, 2016).
Finally, telomeres recruit and interact with many DNA repair factors,
which play crucial functions in telomere maintenance (Doksani & de
Lange, 2014). Thus, current information does not allow identification
of the specific cellular phenotype that leads to progeroid traits
observed in Ft1 mutant mice. The most likely hypothesis is that all
cellular defects observed in Ft1 mutant MEFs contribute to the
organismal phenotype of mutant animals. It is indeed quite possible
that these defects lead to senescence in most if not all tissues, caus-
ing developmental defects and infertility.
3.1 | Relationships between Ft1, p53, and cancer
We have shown that p53 deficiency in Ft1 mutant MEFs induces cell
over proliferation and rescues the sensitivity to both bleomycin and
hydroxyurea. Consistent with these findings, in Ft1kof/kof mutant
mice, mutations in p53 rescue the body weight and sterility pheno-
types but do not improve survival. Impairment of the p53 function
also ameliorates the progeroid phenotypes in BRCA1-deficient mice
(Cao, Li, Kim, Brodie & Deng, 2003) and in HGPS mouse models
(Varela et al., 2005). However, p53 deficiency worsens the progeroid
phenotype in telomere dysfunctional mice (Begus-Nahrmann et al.,
2009). An explanation for this discrepancy is that p53 deficiency
allows beneficial propagation of damaged cells rescuing certain pro-
geroid traits. However, when cellular damage is extensive and the
regenerative capacity of tissues is severely limited, p53 deficiency
would become deleterious and accelerate aging (Lopez-Otin, Blasco,
Partridge, Serrano & Kroemer, 2013). Our results are consistent with
this model; they indicate that mutations in Ft1 result in a relatively
mild genomic damage that triggers DDR-related checkpoints, which
are abolished by mutations in p53 allowing resumption of cell prolif-
eration.
The relationships between mutations in progeria-related genes
and cancer are also complex. Progeroid models have been used to
study the interplay between aging and cancer, given that age is a
major risk factor for cancer developing. It has been shown that some
forms of progeria can exert a protective role against tumor develop-
ment (de la Rosa et al., 2013). On the other hand, mutations in the
WRN helicase causing a segmental progeroid syndrome have been
associated with an elevated cancer risk (Blander et al., 2000). We
found that Ft1kof mutation does not induce cancer and that p53 Ft1
double-mutant mice do not exhibit an increase in the overall fre-
quency of malignancies. However, p53 ko combined with Ft1 defi-
ciency induced an increase in the diffusion of lymphomas as
compared to the restricted localization of this type of tumor in p53
ko mice. It has been reported that T-cell lymphomas in p53 ko mice
are oligoclonal and generated by a characterized sequence of muta-
tional events (Dudgeon et al., 2014). We therefore hypothesize that
in p53 Ft1 double mutants, this sequence is altered causing multi-
clonality and/or histotype change of lymphomas.
In conclusion, we have shown that mutations in Ft1 affect lamin,
telomeres, DNA repair, and cell senescence. At the organismal level,
these mutations result in a number of phenotypes that have been
previously observed in several progeria mouse models. Thus, we
believe that Ft1 is a new player in both the normal and accelerated
aging processes, and that Ft1 mutant mice will be instrumental to
analyze the interactions between Ft1 and other mouse progeria
genes.
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4 | EXPERIMENTAL PROCEDURES
4.1 | Mice
ES (HEPD0589_6_H06) from C57Bl/6 animals carrying the knockout
first mutations in the Ft1 gene (referred as Ft1 kof) were generated
by the International Knock-out mouse consortium. Injections into
C57Bl/6 blastocyst were performed in EMBL (Monterotondo, Italy).
Chimeras were crossed with C57Bl/6 and heterozygous animals
backcrossed with C57Bl/6 and/or intercrossed. Ft1+/kof were crossed
with p53+/ko (Jacks et al., 1994) animals to obtain double mutants.
Offspring were weaned at 3 weeks, and tail biopsies were geno-
typed and transgene expression analyzed. When needed, mice were
anesthetized by intramuscular Zoletil 20 (Virbac S.A., France), or
euthanized by asphyxiation with carbon dioxide or cervical disloca-
tion.
4.2 | Cells
MEFs were isolated and cultured as described in Rinaldo et al.
(2012). Population doubling (pd) was calculated with the formula Log
(nt/n0) 9 3.33. For Bleomycin and Hydroxyurea sensitivity assay,
cells plated 24 hr in advance were treated with Bleomycin (Sanofi
Aventis) or Hydroxyurea (Sigma) for 7 hr and replaced with medium
w/o drugs. Cell density was calculated 10 days after treatment by
staining with crystal violet (5% in methanol, Sigma) for 10 min and
analyzed by IMAGEJ.
4.3 | Genotyping
Tail biopsies were digested overnight at 56°C with a proteinase K/
SDS solution; genomic DNA (gDNA) was extracted using the
NucleoSpin Tissue columns kit (Macherey-Nagel, Duren, Germany)
following manufacturer’s instructions. Mice were PCR genotyped
using the following primers:
Ft1 E4 F: 50–GTGAAGCAGAAGCTGCCAGGAGT–30;
Ft1 E6 R: 50–AGCTCACCCGAGGTGGGATCAA–30;
p53-X6 F: 50–AGCGTGGTGGTACCTTATGAGC–30;
p53-Neo19 F: 50–GCTATCAGGACATAGCGTTGGC–30;
p53-X7 R: 50–GGATGGTGGTATACTCAGAGCC–30;
4.4 | q-PCR
RNA was extracted using the TRIzol reagent (Invitrogen) according
to manufacturer, after DNaseI treatment (Invitrogen) was reverse
transcribed into cDNA with oligo d(T) primer and OMNISCRIPT RT
KIT (Qiagen). q-PCRs were performed as described (Burla et al.,
2015) using following primers:
Ft1 E3 F: AACCAGTCCTCCACGAAGTGCA;
Ft1 E3 R: TAGGGCTTCGCTATGGGTAGAGCA;
Ft1 E6 F: CCGTCTTTCACCCACTAGTTGAT;
Ft1 E6 R: TTGCGAACGCTCTTTTCACA;
mGAPDH F: GTGGCAAAGTGGAGATTGTTGCC;
mGAPDH R: TGTGCCGTTGAATTTGCCGT;
p21 F: 50–TGTCTGAGCGGCCTGAAGAT–30;
p21 R: 50–CTGCGCTTGGAGTGATAGAA–30
4.5 | Western blotting
Western blotting was carried out as described in Burla et al. (2015).
Filters were incubated with rabbit monoclonal anti-FT1 (Sigma HPA
046300), rabbit anti-actin HRP-conjugated (C-11; Santa Cruz—
sc1615), rabbit anti-p21 (C-19; Santa Cruz—sc397), and rabbit anti-
p53 antibodies produced by S. Soddu as described in Cecchinelli
et al. (2006). Filters were incubated with appropriate HRP-conju-
gated secondary antibodies (Santa Cruz).
4.6 | Immunostaining, FISH, and cytology
For immunostaining, cells were fixed with 3.7% formaldehyde for
10 min at 4°C and permeabilized with 0.25% Triton X-100 in PBS for
5 min. Where indicated, cells were prepermeabilized according to
(Burla et al., 2015). Cells were then incubated with the following anti-
bodies in the presence of 3% BSA: anti-53BP1 (Novus Biologicals
NB100-304), anti-cH2AX (05-636 clone JBW301 Upstate Biotechnol-
ogy), anti-Trf1 (Abcam 1423), anti-Ft1 (Sigma, HPA 046300), and anti-
Lamin A (H102, Santa Cruz Biotechnology sc 20680). Primary antibod-
ies were detected with the pertinent secondary antibodies: anti-rab-
bit-ALEXA 555 (Invitrogen A21430) or anti-goat-FITC (Jackson
Immunoresearch 705-095-003). FISH was carried out according to
Burla et al. (2015). Cytological preparations were examined with a Carl
Zeiss (Thornwood, NY) Axioplan fluorescence microscope equipped
with an HBO100W mercury lamp and a cooled charged-coupled
device (CCD camera; Photometrics CoolSnap HQ). Optical sections
were captured at 0.3 lm Z steps using a Prior Proscan stepping motor
with an EM-CCD camera (Cascade II, Photometrics) connected to a
spinning-disk confocal head (CarvII, Beckton Dickinson) mounted on
an inverted microscope (Eclipse TE2000S, Nikon). Each image is a
maximum-intensity projection of all sections. Images were recorded
using METAMORPH software package (Universal Imaging) and processed
using IMAGEJ (http://imagej.nih.gov) and Adobe Photoshop.
4.7 | Histology, immunohistochemistry, and TRAP
Skin, bone, and heart were fixed in 4% formaldehyde. Tissues were
cleared with ascendant alcohol concentration, embedded in paraffin,
and sectioned at 3.5 lm. Sections were hydrated with descendant
alcohol concentration, stained with Hematoxylin (Carlo Erba) and
Eosin (Sigma), cleared, and mounted with DPX Mountant for Histol-
ogy (Sigma). For cH2AX analysis on paraffin, embedded heart sec-
tions were treated as previously described (Martinez, Ferrara-Romeo,
Flores & Blasco, 2014). Tissues were incubated overnight with an
anti-cH2AX (Abcam 2893) diluted in BSA 3%, Triton X-100 0.1%,
and the day after incubated for 1 hr at room temperature with the
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pertinent secondary antibody (anti-rabbit-ALEXA 555, Invitrogen
A21430). Slides were counterstained with Mayer hematoxilin (Carlo
Erba) and mounted with DPX mounting solution for microscopic
evaluation (Sigma). Pictures were taken with ZEISS-Axio Phot (Zeiss)
microscope connected to Progress-C5 JENO-PTIK camera with the
software PROGRESS MAC (Capture PRO). TRAP staining was performed
according to manufacturer’s instructions (Sigma 387A).
4.8 | X-ray and bone density analysis
Total body X-ray images were taken using Faxitron MX-20 (Faxitron
X-ray Corp.) at 24 kV for 6 s; images captured with Medical Imaging
Film HM Plus (Ferrania). Cervical-thoracic vertebrae angle quantifica-
tion was measured with Photoshop CS6 plugin. Femurs were imaged
using a Faxitron MX20 operating at 24 kV for 4 s. Image density
was determined as previously described (Bassett, van der Spek,
Gogakos & Williams, 2012).
4.9 | Statistics
Kaplan–Meier curves were analyzed using the log-rank (Mantel-Cox)
test. Inheritance of kof allele was analyzed using the Mendelian ratio
for heterozygous mating, and v2 test was applied. The Kolmogorov–
Smirnov test was used to compare gray-level cumulative frequency
distributions in X-ray image quantification. Independent data sets
were compared with the Student’s t test (unpaired, two-tailed).
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